Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Endpoints
Sat, 02/17/18 - 10:44 am
Tags:
FDA, AstraZeneca, Imfinzi, lung cancer, Bavencio, Pfizer, Merck KGaA
FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
Fierce Pharma
Fri, 02/16/18 - 09:35 pm
Tags:
FDA, Pfizer, drug manufacturing, Copaxone, generics
Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst
Fierce Pharma
Fri, 02/16/18 - 09:29 pm
Tags:
Remicade, biosimilars, Pfizer, Merck, JNJ
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Yahoo/Reuters
Thu, 02/15/18 - 10:09 am
Tags:
Merck KGaA, Pfizer, lung cancer, Bavencio, clinical trials
Pfizer taps real world evidence for CVD in new partnership
Pharmafile
Thu, 02/15/18 - 12:04 am
Tags:
Pfizer, atrial fibrillation, RWE, real world evidence, BC Platforms
Top 10 most productive workforces in biopharma
Fierce Pharma
Mon, 02/12/18 - 11:03 am
Tags:
Pharma, pharma employees, productivity, Gilead Sciences, Celgene, Pfizer, AbbVie, Biogen
Research in pharma less and less profitable, economic return as little as 3%
GoinPharma
Sat, 02/10/18 - 09:28 am
Tags:
R&D, GSK, Pfizer
AbbVie, Pfizer in another close TV ad spending race to kick off 2018
Fierce Pharma
Wed, 02/7/18 - 10:02 am
Tags:
AbbVie, Pfizer, drug ads, television ads
Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J
JD Supra
Tue, 02/6/18 - 08:40 pm
Tags:
biosimilars, Pfizer, JNJ, antitrust, Remicade, Inflectra
Pfizer, Astellas peg Xtandi expansion on PROSPER data
Biopharma Dive
Mon, 02/5/18 - 07:09 pm
Tags:
Pfizer, Astellas, Xtandi, prostate cancer
Glaxo, Reckitt Submit Only Bids for Pfizer's Consumer Unit
Yahoo/Bloomberg
Sun, 02/4/18 - 11:57 am
Tags:
GSK, Reckitt Benckiser, M&A, Pfizer, consumer health
Here's What Pfizer's Saying About Its Future
Motley Fool
Sat, 02/3/18 - 09:13 am
Tags:
Pfizer
Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls
TheStreet.com
Sat, 02/3/18 - 09:07 am
Tags:
pharma execs, M&A, earnings, drug pricing, Pfizer, Ian Read, Merck, Ken Frazier, Enrique Conterno, Eli Lilly
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Biopharma Dive
Thu, 02/1/18 - 09:45 pm
Tags:
Pfizer, drug manufacturing, generics, Momenta Pharmaceuticals, Copaxone, Novartis
The Viagra effect: Sales of Lilly's ED drug Cialis slide after little blue pill goes generic
Fierce Pharma
Wed, 01/31/18 - 03:16 pm
Tags:
Eli Lilly, Pfizer, erectile dysfunction, Viagra, Cialis, generics
Racing to replace opioids, biopharma is betting on pain drugs with a checkered past
Stat
Wed, 01/31/18 - 11:00 am
Tags:
opioids, painkillers, NGF inhibitors, Regeneron, Pfizer, Eli Lilly, NGF blockers
Pfizer benefits from tax reform, still vague on M&A
Biopharma Dive
Tue, 01/30/18 - 10:44 pm
Tags:
Pfizer, tax reform, M&A
What will Pfizer do with tax reform? It won't revive a split, CFO says
Fierce Pharma
Tue, 01/30/18 - 06:17 pm
Tags:
Pfizer, tax reform
Pfizer profit tops estimates, books $11 bln tax gain
Yahoo/Reuters
Tue, 01/30/18 - 10:55 am
Tags:
Pfizer, earnings
Pfizer sweeps out a lineup of neuroscience drugs — as well as cancer and NASH programs — into the scrap heap
Endpoints
Tue, 01/30/18 - 09:52 am
Tags:
Pfizer, Neurosciences, NASH, Bavencio

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.